Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00179751
Status:
TERMINATED
Last Update Posted:
2005-11-07
First Post:
2005-09-10
Brief Title:
A Phase III Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas
Sponsor:
Celgene Corporation
Organization:
Celgene
Organization Data
Organization:
Celgene
Class:
INDUSTRY
Study ID:
CC-5013-PANC-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celgene Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Prologue Research International | INDUSTRY |